# A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-375

> **NCT04221360** · PHASE1 · UNKNOWN · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 26 (estimated)

## Conditions studied

- Type2 Diabetes Mellitus

## Interventions

- **DRUG:** CKD-375
- **DRUG:** D390

## Key facts

- **NCT ID:** NCT04221360
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-29
- **Primary completion:** 2020-03-06
- **Final completion:** 2020-06-08
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2020-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04221360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04221360, "A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-375". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04221360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*